analyst
-
Spine
Is Medtronic a Buy? What Analyst Day Revealed
By Stephen D., Simpson, | More Articles June 11, 2014 | Comments (0) Medtronic‘s (NYSE: MDT ) June 6 analyst day was by no means light fare,…
Read More » -
Global spine surgery devices market to grow to $14.8 billion in five years
August 27, 2012 11:13 am by Arundhati Parmar | 0 Comments Growing at a compounded annual rate of 5.1 percent, the global spine…
Read More » -
Global Spinal Devices and Biologics Market to Grow 6.9% Annually
The global spinal device and biologics market is expected to grow at a compound annual growth rate of 6.9 percent…
Read More » -
U.S. Market for Spinal Implants & VCF 2012
NEW YORK, May 9, 2012 /PRNewswire via COMTEX/ — Reportlinker.com announces that a new market research report is available in…
Read More » -
Recon
Orthopedic survey: U.S. knee/hip market has hit bottom
A survey of orthopedic docs by investment bank Leerink Swann yields mixed messages for the U.S. market for hip and…
Read More » -
Implantable Medical Devices Market
NEW YORK, March 19, 2012 /PRNewswire via COMTEX/ — Reportlinker.com announces that a new market research report is available in…
Read More » -
Recon
Get Hip to These Orthopedic Players
Credit Suisse We expect sales growth for Stryker of about 5% in 2011-2016, stemming from a rebound to trend-line growth…
Read More » -
Orthopedic Devices Market to 2017 – Spinal Surgery and Advanced Prosthetics Products to be Major Growth Driver By Reportlinker
NEW YORK, Feb. 21, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:…
Read More » -
NuVasive (NUVA) Shares Given New $15.00 Price Target by Kaufman Brothers Analysts
Equities research analysts at Kaufman Brothers lowered their price target on shares of NuVasive (NASDAQ: NUVA) from $21.00 to $15.00 in a research issued…
Read More » -
MAKO Surgical (MAKO) Shares Upgraded to a “Buy” Rating by Summer Street Analysts.
MAKO Surgical (NASDAQ: MAKO) was upgraded by equities research analysts at Summer Street from a “neutral” rating to a “buy” rating…
Read More » -
Financial
Moody’s: U.S. medical device firms face soft organic growth prospects
By Stewart Eisenhart, Emergo Group U.S. medical device manufacturers dealing with lower market demand and rising pricing pressure will rely more…
Read More » -
MAKO Surgical (MAKO) Given New $35.00 Price Target by Piper Jaffray (PJC) Analysts.
Equities research analysts at Piper Jaffray (NYSE: PJC) boosted their price target on shares of MAKO Surgical (NASDAQ: MAKO) to $35.00…
Read More » -
Jefferies Remains Positive On NUVA, Lowers PT To $34 From $36
Despite near-term challenges and uncertainty in the spine market, Jefferies said that it remains positive on the NuVasive, Inc. (NASDAQ: NUVA)…
Read More » -
Relatively High EPS Growth Detected in Shares of RTI Biologics in the Health Care Supplies Industry
Dec 27, 2010 (SmarTrend(R) News Watch via COMTEX) — Below are the top 5 companies in the Health Care Supplies…
Read More » -
Orthofix International (NASDAQ: OFIX) Upgraded to an “Outperform” Rating
Equities research analysts at Zacks Investment Research upgraded shares of Orthofix International (NASDAQ: OFIX) from a “neutral” rating to an “outperform” rating…
Read More »